Order Article Reprints

Li H-Z, Liu Q-Q, Chang D-H, Li S-X, Yang L-T, Zhou P, Deng J-B, Huang C-H, Xiao Y-D. Identification of NOX4 as a New Biomarker in Hepatocellular Carcinoma and Its Effect on Sorafenib Therapy. Biomedicines. 2023; 11(8):2196. https://doi.org/10.3390/biomedicines11082196

Li, Hui-Zhou, Qing-Qing Liu, De-Hua Chang, Shu-Xian Li, Long-Tao Yang, Peng Zhou, Jiang-Bei Deng, Chang-Hao Huang, and Yu-Dong Xiao. 2023. "Identification of NOX4 as a New Biomarker in Hepatocellular Carcinoma and Its Effect on Sorafenib Therapy" Biomedicines 11, no. 8: 2196. https://doi.org/10.3390/biomedicines11082196

Li, H.-Z., Liu, Q.-Q., Chang, D.-H., Li, S.-X., Yang, L.-T., Zhou, P., Deng, J.-B., Huang, C.-H., & Xiao, Y.-D. (2023). Identification of NOX4 as a New Biomarker in Hepatocellular Carcinoma and Its Effect on Sorafenib Therapy. Biomedicines, 11(8), 2196. https://doi.org/10.3390/biomedicines11082196